Subscribe
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
ESMO 2025 - Wrap-Up: Triple-Negative Breast Cancer
ASCO 2025 - Wrap-Up: Triple-Negative Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quiz
Press Releases
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma
ASH Highlights
Filter by Topic
ASH 2011 Annual Meeting
ASH 2013 Annual Meeting
ASH 2014 - Castleman's Disease
ASH 2014 - CLL
ASH 2015 - Multiple Myeloma
ASH 2015 – Castleman’s Disease, Lymphoma, and CLL
ASH 2015 – Leukemia
ASH 2017
ASH 2017 - Acute Myeloid Leukemia
ASH 2019 Wrap-up
Siltuximab Efficacy in Multicentric Castleman’s Disease Is Independent of Baseline Symptom Burden
ASH 2014 - Castleman's Disease
,
ASH Highlights
Conference Correspondent
Read Article
Adding Rituximab to CHOP Improves Clinical Outcomes in Mantle-Cell Lymphoma
ASH 2014 - Castleman's Disease
,
ASH Highlights
Conference Correspondent
Read Article
Long-Term Maintenance with Rituximab in Elderly Patients with Mantle-Cell Lymphoma
ASH 2014 - Castleman's Disease
,
ASH Highlights
Conference Correspondent
Read Article
Antagonism of Immune Effector Function by Ibrutinib or Obinutuzumab versus Rituximab
ASH 2014 - Castleman's Disease
,
ASH Highlights
Conference Correspondent
Read Article
Ibrutinib Alone or in Combination with Dexamethasone for Relapsed/Refractory Multiple Myeloma
ASH 2014 - Castleman's Disease
,
ASH Highlights
Conference Correspondent
Read Article
Data from the SPARK Study: Mutational Analysis of Patients with Primary Resistance to Ibrutinib in Relapsed/Refractory Mantle-Cell Lymphoma
ASH 2014 - Castleman's Disease
,
ASH Highlights
Conference Correspondent
Read Article
International Research Agenda for Multicentric Castleman’s Disease
ASH 2014 - Castleman's Disease
,
ASH Highlights
Conference Correspondent
Read Article
Updates on Treatments for Castleman’s Disease
ASH 2014 - Castleman's Disease
,
ASH Highlights
Conference Correspondent
Read Article
Pathology and Diagnosis of Multicentric Castleman’s Disease
ASH 2014 - Castleman's Disease
,
ASH Highlights
Conference Correspondent
Read Article
The Clinical Features of Multicentric Castleman's Disease
ASH 2014 - Castleman's Disease
,
ASH Highlights
Conference Correspondent
Read Article
Page 13 of 15
10
11
12
13
14
15
Top Trending Articles
1.
HOPA Highlights: What's New in 2025?
2.
Immunotherapy Helps Navy Veteran Beat Stage 4 Lung Cancer
3.
Peer Navigation Intervention Aims to Boost Childhood Cancer Clinical Trial Participation
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
ESMO 2025 - Wrap-Up: Triple-Negative Breast Cancer
ASCO 2025 - Wrap-Up: Triple-Negative Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quiz
Press Releases
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma